🚧 Under construction — VoTechWorks is being built. A free tech program — complimentary, as our commitment to get America working.
voTechWorksGrade 13 · a vocational technology learning center, by urbanicity
newSchoolWorks.com › VoTechWorks › Health & Personal Services › EKG Technician › Cardiac Anatomy and Physiology for EKG Technicians › Lesson 9
HLT-EKGT89-02 · Lesson 9 · 5 clock hours · theory

The Autonomic Nervous System and Hormonal Control of the Heart

Objective. Students will describe how the sympathetic and parasympathetic divisions of the autonomic nervous system alter heart rate and contractility, and explain how common cardiovascular medications (rate-controlling agents) exploit these pathways.

⚠ Pending professional review

This lesson, its worked examples and its practice questions has not yet been verified by a licensed clinician in the field or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.

VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.

The Autonomic Nervous System and the Heart

Your heart does not beat because you decide to make it beat. The autonomic nervous system (ANS) runs that job automatically, moment to moment, without any conscious effort. As an EKG technician, you will watch heart rate and rhythm change in real time. Understanding why those changes happen — and how common medications influence them — makes you a sharper observer and a safer member of the care team.

The ANS has two divisions that act as opposites: the sympathetic division and the parasympathetic division. Both send nerve fibers directly to the heart.

Sympathetic Division: "Fight or Flight"

The sympathetic division prepares the body for activity and stress. Its nerve fibers reach the heart through the cardiac accelerator nerves. When stimulated, these nerves release the neurotransmitter norepinephrine, which binds to beta-1 adrenergic receptors on cardiac tissue.

The result is a predictable cluster of effects:

The hormone epinephrine (adrenaline), released from the adrenal medulla during stress, mimics these same effects by binding to the same beta-1 receptors. This is why a frightened or exercising patient will show sinus tachycardia on your monitor.

Parasympathetic Division: "Rest and Digest"

The parasympathetic division slows the heart down and conserves energy. The primary pathway to the heart runs through the vagus nerve (cranial nerve X). When activated, the vagus nerve releases the neurotransmitter acetylcholine, which binds to muscarinic receptors on the SA node and AV node.

The effects are the mirror image of sympathetic stimulation:

High vagal tone is normal during sleep and in well-trained athletes. Sudden vagal surges — from bearing down, vomiting, or carotid sinus pressure — can cause a dramatic but usually brief drop in heart rate visible on the monitor.

Hormonal Control

Beyond direct nerve fibers, circulating hormones fine-tune cardiac function. Epinephrine and norepinephrine from the adrenal medulla amplify sympathetic effects throughout the body. Thyroid hormones increase the sensitivity of the heart to catecholamines, which is why hyperthyroid patients often show persistent tachycardia. These hormonal signals explain why conditions far from the heart — an overactive thyroid, a severe infection, blood loss — all show up as rhythm changes you can see on the EKG strip.

How Common Medications Exploit These Pathways

Rate-controlling medications used in cardiac patients work by targeting the exact receptors and channels described above. As an EKG technician, you will not prescribe or administer any of these agents — that is outside your scope of practice. Your role is to observe the tracing, report findings accurately, and recognize that a patient's medication history can explain what you see on the monitor.

Beta-blockers (e.g., metoprolol, atenolol) block beta-1 adrenergic receptors. They reduce sympathetic stimulation at the SA and AV nodes, slowing heart rate and lengthening the PR interval. On the monitor, expect a slower, steadier rate.

Non-dihydropyridine calcium channel blockers (e.g., diltiazem, verapamil) reduce the flow of calcium ions into SA and AV nodal cells, which slows spontaneous depolarization and depresses conduction. The clinical effect is similar to beta-blockade: slower rate, longer PR interval, and reduced contractility.

Atropine works on the parasympathetic side. It is a muscarinic receptor antagonist — it blocks acetylcholine's effect at the SA and AV nodes. With parasympathetic braking removed, sympathetic tone dominates and heart rate increases. Atropine is used clinically to treat symptomatic bradycardia. On the monitor, you will see the rate climb after administration.

Safety and Scope of Practice

Knowing how these drugs work does not authorize you to make treatment decisions. If you observe an unexpected rhythm change — sudden bradycardia, a new AV block, a rate that climbs after a medication is given — your duty is to:

1. Confirm lead placement and artifact are not the cause.

2. Report the finding promptly and accurately to the supervising nurse or clinician.

3. Document what you observed and when.

Never adjust a medication dose, suggest a medication, or delay reporting to investigate further on your own. Patient safety depends on fast, accurate communication within the team.

Key terms9

Sympathetic divisionThe branch of the autonomic nervous system that increases heart rate, AV conduction speed, and contractility, primarily through norepinephrine acting on beta-1 adrenergic receptors.
Parasympathetic divisionThe branch of the autonomic nervous system that slows heart rate and AV conduction, primarily through acetylcholine released by the vagus nerve acting on muscarinic receptors.
Vagus nerveCranial nerve X; the main parasympathetic pathway to the heart, slowing the SA node and depressing AV conduction when activated.
NorepinephrineNeurotransmitter released by sympathetic nerve endings; binds to beta-1 receptors on the heart to increase rate and contractility.
AcetylcholineNeurotransmitter released by vagal nerve endings; binds to muscarinic receptors on the SA and AV nodes to slow heart rate and conduction.
Beta-blockerA class of drugs that blocks beta-1 adrenergic receptors, reducing heart rate and slowing AV conduction by dampening sympathetic effects.
AtropineA muscarinic receptor antagonist that blocks acetylcholine at the SA and AV nodes, removing parasympathetic braking and thereby increasing heart rate.
ChronotropyThe property relating to heart rate; positive chronotropy means increased rate (sympathetic effect), negative chronotropy means decreased rate (parasympathetic effect).
DromotropyThe property relating to conduction velocity through the AV node; positive dromotropy speeds conduction (shortens PR interval), negative dromotropy slows it (lengthens PR interval).
In class: Comparison table: students complete a structured table contrasting sympathetic versus parasympathetic effects on heart rate, AV conduction speed, and contractility; the table is then used as a reference for the medication discussion. · Mechanism matching exercise: students receive a list of drug classes commonly encountered in cardiac monitoring settings (beta-blockers, calcium channel blockers, atropine) and match each to its autonomic mechanism of action and the expected change on a monitor tracing (slower rate, faster rate); scope of practice boundaries—EKG technicians observe and report, they do not prescribe or administer—are explicitly reviewed. · Group quiz game: instructor poses five rapid-fire questions (e.g., 'Which neurotransmitter slows the SA node?'); groups write answers on mini whiteboards and reveal simultaneously; instructor corrects errors immediately.
Materials: Autonomic comparison table worksheet, medication mechanism matching handout, mini whiteboards, NHA CET study guide, trade-level pharmacology reference for allied health (drug class overview only)
Check: Completed comparison table and matching exercise collected; pass standard is 80% accuracy on combined 15 items; scope-of-practice boundary review confirmed by instructor before lesson ends.

Practice check8

Answer each question, then check it. Nothing is recorded; this is your own practice.

Cardiac Anatomy and Physiology
1. Which neurotransmitter is released by vagal nerve endings and slows the SA node?
Electrocardiography and Monitoring
2. A patient's monitor shows a suddenly slower heart rate with a lengthening PR interval. You review the medication administration record and note a beta-blocker was given recently. What is the most likely mechanism?
Electrocardiography and Monitoring
3. Atropine is administered to a patient in symptomatic bradycardia. What change would you expect to see on the monitor tracing?
Cardiac Anatomy and Physiology
4. Which of the following correctly describes the effect of sympathetic stimulation on the heart?
Patient Care and Safety
5. An EKG technician notices a rhythm change during monitoring after a new medication is infused. What is the appropriate next action within the technician's scope of practice?
Cardiac Anatomy and Physiology
6. A well-trained long-distance runner comes in for a routine EKG and has a resting heart rate of 48 bpm with a normal rhythm. Which physiological explanation best accounts for this finding?
Electrocardiography and Monitoring
7. Non-dihydropyridine calcium channel blockers such as diltiazem slow heart rate primarily by:
Cardiac Anatomy and Physiology
8. During a group quiz game, the instructor asks: 'What term describes the property of increased strength of myocardial contraction?' Which answer is correct?
Record this lesson on my transcript. Sign in with your key and enrollment email to record lessons (enroll free if you have no key). This page stays open to read and practise.